Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 231

1.

Evaluation of the efficacy of a virtual reality-based safety training and human factors training method: study protocol for a randomised-controlled trial.

Nykänen M, Puro V, Tiikkaja M, Kannisto H, Lantto E, Simpura F, Uusitalo J, Lukander K, Räsänen T, Teperi AM.

Inj Prev. 2019 Aug 17. pii: injuryprev-2019-043304. doi: 10.1136/injuryprev-2019-043304. [Epub ahead of print]

PMID:
31422365
2.

Collection, transport and storage procedures for blood culture specimens in adult patients: recommendations from a board of Italian experts.

De Plato F, Fontana C, Gherardi G, Privitera GP, Puro V, Rigoli R, Viaggi B, Viale P.

Clin Chem Lab Med. 2019 Jul 26. pii: /j/cclm.ahead-of-print/cclm-2018-1146/cclm-2018-1146.xml. doi: 10.1515/cclm-2018-1146. [Epub ahead of print]

PMID:
31348753
3.

[Good practices for the surveillance and control of antimicrobial resistance].

Moro ML, Ciofi Degli Atti M, D'Amore C, Diegoli G, Forni S, Gagliotti C, Gemmi F, Iannazzo S, Miraglia V, Pan A, Pantosti A, Pitatlis S, Puro V, Ricchizzi E, Sarnelli B, Torti C, Zotti C.

Epidemiol Prev. 2019 Mar-Jun;43(2-3):185-193. doi: 10.19191/EP19.2-3.P185.058. Italian.

4.

Unawareness of HCV serostatus among persons newly diagnosed with HIV.

Scognamiglio P, Navarra A, Orchi N, De Carli G, Pittalis S, Mastrorosa I, Visco Comandini U, Agrati C, Antinori A, Puro V, Ippolito G, Girardi E.

J Infect Public Health. 2019 Feb 5. pii: S1876-0341(19)30057-7. doi: 10.1016/j.jiph.2019.01.055. [Epub ahead of print]

5.

Local transmission of chikungunya in Rome and the Lazio region, Italy.

Vairo F, Mammone A, Lanini S, Nicastri E, Castilletti C, Carletti F, Puro V, Di Lallo D, Panella V, Varrenti D, Scaramozzino P, di Caro A, Scognamiglio P, Capobianchi MR, Ippolito G; Chikungunya Lazio Outbreak Group.

PLoS One. 2018 Dec 21;13(12):e0208896. doi: 10.1371/journal.pone.0208896. eCollection 2018.

6.

Epidemiological investigation of an Acinetobacter baumannii outbreak using core genome multilocus sequence typing.

Venditti C, Vulcano A, D'Arezzo S, Gruber CEM, Selleri M, Antonini M, Lanini S, Marani A, Puro V, Nisii C, Di Caro A.

J Glob Antimicrob Resist. 2019 Jun;17:245-249. doi: 10.1016/j.jgar.2018.11.027. Epub 2018 Dec 13.

PMID:
30553929
7.

The Surveillance of Chikungunya Virus in a Temperate Climate: Challenges and Possible Solutions from the Experience of Lazio Region, Italy.

Vairo F, Di Pietrantonj C, Pasqualini C, Mammone A, Lanini S, Nicastri E, Castilletti C, Ferraro F, Di Bari V, Puro V, Scognamiglio P, Di Caro A, Capobianchi MR, Ippolito G.

Viruses. 2018 Sep 14;10(9). pii: E501. doi: 10.3390/v10090501. Review.

8.

Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study.

Lanini S, Scognamiglio P, Mecozzi A, Lombardozzi L, Vullo V, Angelico M, Gasbarrini A, Taliani G, Attili AF, Perno CF, De Santis A, Puro V, Cerqua F, D'Offizi G, Pellicelli A, Armignacco O, Mennini FS, Siciliano M, Girardi E, Panella V, Ippolito G; members of the Lazio Region HCV treatment group.

BMC Infect Dis. 2018 May 16;18(1):223. doi: 10.1186/s12879-018-3125-6.

9.

Occupational transmission of an Orthopoxvirus infection during an outbreak in a colony of Macaca tonkeana in Lazio Region, Italy, 2015.

Puro V, Fusco FM, Castilletti C, Carletti F, Colavita F, Agrati C, Di Caro A, Capobianchi MR, Ippolito G.

Zoonoses Public Health. 2018 Aug;65(5):578-583. doi: 10.1111/zph.12459. Epub 2018 Mar 7.

PMID:
29512303
10.

Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis among persons living with HIV/AIDS in Italy: a Nationwide, cross-sectional study among patients on antiretrovirals and their treating HIV physicians.

Palummieri A, De Carli G, Rosenthal É, Cacoub P, Mussini C, Puro V; PrEPventHIV Italy Study Group.

BMC Infect Dis. 2017 Nov 28;17(1):734. doi: 10.1186/s12879-017-2819-5.

11.

An outbreak of chickenpox in an asylum seeker centre in Italy: outbreak investigation and validity of reported chickenpox history, December 2015-May 2016.

Vairo F, Di Bari V, Panella V, Quintavalle G, Torchia S, Serra MC, Sinopoli MT, Lopalco M, Ceccarelli G, Ferraro F, Valle S, Bordi L, Capobianchi MR, Puro V, Scognamiglio P, Ippolito G; The Outbreak Investigation Group.

Euro Surveill. 2017 Nov;22(46). doi: 10.2807/1560-7917.ES.2017.22.46.17-00020.

12.

A large ongoing outbreak of hepatitis A predominantly affecting young males in Lazio, Italy; August 2016 - March 2017.

Lanini S, Minosse C, Vairo F, Garbuglia A, Di Bari V, Agresta A, Rezza G, Puro V, Pendenza A, Loffredo MR, Scognamiglio P, Zumla A, Panella V, Ippolito G, Capobianchi MR; Gruppo Laziale Sorveglianza Epatiti Virali (GLaSEV).

PLoS One. 2017 Nov 10;12(11):e0185428. doi: 10.1371/journal.pone.0185428. eCollection 2017.

13.

Fatal Outbreak in Tonkean Macaques Caused by Possibly Novel Orthopoxvirus, Italy, January 2015 1.

Cardeti G, Gruber CEM, Eleni C, Carletti F, Castilletti C, Manna G, Rosone F, Giombini E, Selleri M, Lapa D, Puro V, Di Caro A, Lorenzetti R, Scicluna MT, Grifoni G, Rizzoli A, Tagliapietra V, De Marco L, Capobianchi MR, Autorino GL.

Emerg Infect Dis. 2017 Dec;23(12):1941-1949. doi: 10.3201/eid2312.162098. Epub 2017 Dec 17.

14.

HIV Self-Testing in Italy.

Pittalis S, Orchi N, De Carli G, Navarra A, Chiaradia G, Puro V, Girardi E.

J Acquir Immune Defic Syndr. 2017 Nov 1;76(3):e84-e85. doi: 10.1097/QAI.0000000000001507. No abstract available.

PMID:
28746168
15.

Letter to the editor: Trends in tuberculosis notification rates by country of origin in the metropolitan area of Rome, 2010 to 2015.

Sañé Schepisi M, Scognamiglio P, D'Amato M, Girardi E, Puro V.

Euro Surveill. 2017 Jul 6;22(27). doi: 10.2807/1560-7917.ES.2017.22.27.30570. No abstract available.

16.

Short-term economic impact of the Zika virus outbreak.

Macciocchi D, Lanini S, Vairo F, Zumla A, Figueiredo LT, Lauria FN, Strada G, Brouqui P, Puro V, Krishna S, Kremsner P, Scognamiglio P, Köhler C, Nicastri E, Di Caro A, Cieri RM, Ioannidis JP, Kobinger G, Burattini MN, Ippolito G.

New Microbiol. 2016 Oct;39(4):287-289.

17.

Enabling Rapid Response to the 2014-2016 Ebola Epidemic: The Experience and the Results of the National Institute for Infectious Diseases Lazzaro Spallanzani.

Nicastri E, Castilletti C, Biava M, Fusco FM, Petrosillo N, Puro V, Lauria FN, Capobianchi MR, Di Caro A, Ippolito G.

Adv Exp Med Biol. 2017;972:103-122. doi: 10.1007/5584_2016_134.

PMID:
27864803
18.

Three cases of Zika virus imported in Italy: need for a clinical awareness and evidence-based knowledge.

Nicastri E, Pisapia R, Corpolongo A, Fusco FM, Cicalini S, Scognamiglio P, Castilletti C, Bordi L, Di Caro A, Capobianchi MR, Puro V, Ippolito G.

BMC Infect Dis. 2016 Nov 11;16(1):669.

19.

Isolation of KPC 3-producing Enterobacter aerogenes in a patient colonized by MDR Klebsiella pneumoniae.

Venditti C, Villa L, Capone A, Fortini D, D'Arezzo S, Nisii C, Bordi E, Puro V, Antonini M, Carattoli A, Cataldo MA, Petrosillo N, Di Caro A.

New Microbiol. 2016 Oct;39(4):310-313. Epub 2016 Jun 10.

20.

Sampling Surfaces for Ebola Virus Persistence After Cleaning Procedures in High-Level Isolation Settings: The Experience With 2 Patients at the Lazzaro Spallanzani National Institute for Infectious Diseases.

Puro V, Fusco FM, Petrecchia A, Pittalis S, Antonini M, Bordi L, Lalle E, Castilletti C, Di Caro A, Capobianchi MR, Ippolito G.

Infect Control Hosp Epidemiol. 2016 Jun;37(6):723-5. doi: 10.1017/ice.2016.46. No abstract available.

PMID:
27198605
21.

Surgical site infection after caesarean section: space for post-discharge surveillance improvements and reliable comparisons.

Ferraro F, Piselli P, Pittalis S, Ruscitti LE, Cimaglia C, Ippolito G, Puro V; Centro di Riferimento per le Infezioni associate alle Pratiche Assistenziali Latium Region Group.

New Microbiol. 2016 Apr;39(2):134-8.

22.

Zika virus and microcephaly: is the correlation causal or coincidental?

Liuzzi G, Puro V, Lanini S, Vairo F, Nicastri E, Capobianchi MR, Di Caro A, Piacentini M, Zumla A, Ippolito G.

New Microbiol. 2016 Apr;39(2):83-5. No abstract available.

23.

Zika virus in saliva-New challenges for prevention of human to human transmission.

Liuzzi G, Nicastri E, Puro V, Zumla A, Ippolito G.

Eur J Intern Med. 2016 Sep;33:e20-1. doi: 10.1016/j.ejim.2016.04.022. Epub 2016 May 11. No abstract available.

PMID:
27179414
24.

Non-randomised Ebola trials--lessons for optimal outbreak research.

Ippolito G, Lanini S, Brouqui P, Di Caro A, Vairo F, Fusco FM, Krishna S, Capobianchi MR, Kyobe-Bosa H, Puro V, Wölfel R, Avsic-Zupanc T, Ioannidis JP, Portella G, Kremsner P, Dar O, Bates M, Zumla A.

Lancet Infect Dis. 2016 Apr;16(4):407-8. doi: 10.1016/S1473-3099(16)00132-8. No abstract available.

PMID:
27036341
25.

Longitudinal characterization of dysfunctional T cell-activation during human acute Ebola infection.

Agrati C, Castilletti C, Casetti R, Sacchi A, Falasca L, Turchi F, Tumino N, Bordoni V, Cimini E, Viola D, Lalle E, Bordi L, Lanini S, Martini F, Nicastri E, Petrosillo N, Puro V, Piacentini M, Di Caro A, Kobinger GP, Zumla A, Ippolito G, Capobianchi MR.

Cell Death Dis. 2016 Mar 31;7:e2164. doi: 10.1038/cddis.2016.55.

26.

How Much do Needlestick Injuries Cost? A Systematic Review of the Economic Evaluations of Needlestick and Sharps Injuries Among Healthcare Personnel.

Mannocci A, De Carli G, Di Bari V, Saulle R, Unim B, Nicolotti N, Carbonari L, Puro V, La Torre G.

Infect Control Hosp Epidemiol. 2016 Jun;37(6):635-46. doi: 10.1017/ice.2016.48. Epub 2016 Mar 29. Review.

27.

Zika virus and microcephaly: is the correlation, causal or coincidental?

Liuzzi G, Puro V, Vairo F, Nicastri E, Capobianchi MR, Di Caro A, Piacentini M, Zumla A, Ippolito G.

New Microbiol. 2016 Mar 10;39(2). [Epub ahead of print] No abstract available.

28.

How many people are living with undiagnosed HIV infection? An estimate for Italy, based on surveillance data.

Mammone A, Pezzotti P, Regine V, Camoni L, Puro V, Ippolito G, Suligoi B, Girardi E.

AIDS. 2016 Apr 24;30(7):1131-6. doi: 10.1097/QAD.0000000000001034.

29.

Criteria for discharge of patients with Ebola virus diseases in high-income countries.

Bevilacqua N, Nicastri E, Chinello P, Puro V, Petrosillo N, Di Caro A, Capobianchi MR, Lanini S, Vairo F, Pletschette M, Zumla A, Ippolito G; INMI Ebola Team.

Lancet Glob Health. 2015 Dec;3(12):e739-40. No abstract available. Erratum in: Lancet Glob Health. 2016 Jan;4(1):e27.

30.

An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim Project.

Andreoni M, Marcotullio S, Puro V, De Carli G, Tambussi G, Nozza S, Gori A, Rusconi S, Santoro MM, Clementi M, Perno CF, d'Arminio Monforte A, Maggiolo F, Castagna A, De Luca A, Galli M, Giacomelli A, Borderi M, Guaraldi G, Calcagno A, Di Perri G, Bonora S, Mussini C, Di Biagio A, Puoti M, Bruno R, Zuccaro V, Antinori A, Cinque P, Croce D, Restelli U, Rizzardini G, Lazzarin A.

New Microbiol. 2015 Oct;38(4):443-90. Review.

31.

First Italian Ebola virus disease case: management of hospital internal and external communication.

Salce L, Barbato S, Renna D, Bianchini F, Vaccaro P, Mazzeo F, Gasparini A, Rizza C, Lanfranchi E, Petrosillo N, Nicastri E, Di Caro A, Capobianchi MR, Puro V, Ippolito G; INMI EBOV Team.

New Microbiol. 2015 Oct;38(4):565-70. Epub 2015 Oct 20.

32.

Ebola virus disease complicated with viral interstitial pneumonia: a case report.

Petrosillo N, Nicastri E, Lanini S, Capobianchi MR, Di Caro A, Antonini M, Puro V, Lauria FN, Shindo N, Magrini N, Kobinger GP, Ippolito G; INMI EBOV Team.

BMC Infect Dis. 2015 Oct 16;15:432. doi: 10.1186/s12879-015-1169-4.

33.

Disinfection of personal protective equipment for management of Ebola patients.

Puro V, Pittalis S, Chinello P, Nicastri E, Petrosillo N, Antonini M, Ippolito G; Ebola INMI Task Force.

Am J Infect Control. 2015 Dec 1;43(12):1375-6. doi: 10.1016/j.ajic.2015.07.040. Epub 2015 Sep 26. No abstract available.

PMID:
26409916
34.

A 2009 cross-sectional survey of procedures for post-mortem management of highly infectious disease patients in 48 isolation facilities in 16 countries: data from EuroNHID.

Fusco FM, Scappaticci L, Schilling S, De Iaco G, Brouqui P, Maltezou HC, Brodt HR, Bannister B, Ippolito G, Puro V; EuroNHID Working Group.

Infection. 2016 Feb;44(1):57-64. doi: 10.1007/s15010-015-0831-5. Epub 2015 Aug 13.

PMID:
26267332
35.

Ebola: missed opportunities for Europe-Africa research.

Ippolito G, Lanini S, Brouqui P, Di Caro A, Vairo F, Abdulla S, Fusco FM, Krishna S, Capobianchi MR, Kyobe-Bosa H, Lewis DJ, Puro V, Wolfel R, Avsic-Zupanc T, Dar O, Mwaba P, Bates M, Heymann D, Zumla A.

Lancet Infect Dis. 2015 Nov;15(11):1254-5. doi: 10.1016/S1473-3099(15)00236-4. Epub 2015 Jul 28. No abstract available.

PMID:
26231479
36.

Epidemiology of HEV in the Mediterranean basin: 10-year prevalence in Italy.

Lanini S, Garbuglia AR, Lapa D, Puro V, Navarra A, Pergola C, Ippolito G, Capobianchi MR.

BMJ Open. 2015 Jul 14;5(7):e007110. doi: 10.1136/bmjopen-2014-007110.

37.

Adopting a global safety standard for the prevention of Ebola needle-stick exposures.

De Carli G, Fusco FM, Puro V, Ippolito G; EuroNHID Working Group.

Infect Control Hosp Epidemiol. 2015 Jun;36(6):745-6. doi: 10.1017/ice.2015.62. No abstract available.

38.

[Prevention of accidental needle sticks before the Directive 2010/32/EU in a sample of Italian hospitals].

Di Bari V, De Carli G, Puro V; Gruppo Collaborativo dello Studio Italiano sul Rischio Occupazionale da HIV e Altri Patogeni a Trasmissione Ematica (SIROH).

Med Lav. 2015 May 4;106(3):186-205. Italian.

PMID:
25951865
39.

Hospital preparedness for knowledge-based response to Ebola and other emerging infectious diseases: A continuous challenge.

Di Caro A, Puro V, Fusco FM, Capobianchi MR, Ippolito G; INMI Preparedness and Response Group.

Eur J Intern Med. 2015 Jul;26(6):454-5. doi: 10.1016/j.ejim.2015.04.012. Epub 2015 Apr 29. No abstract available.

PMID:
25933702
40.

Considerations regarding safe transport and transfer for Ebola patients in western countries.

Fusco FM, Puro V, Ippolito G.

Intensive Care Med. 2015 Jun;41(6):1175-6. doi: 10.1007/s00134-015-3825-y. Epub 2015 Apr 29. No abstract available.

PMID:
25920544
41.

Radiographic imaging in Ebola Virus Disease: protocol to acquire chest radiographs.

Busi Rizzi E, Puro V, Schinina' V, Nicastri E, Petrosillo N, Ippolito G.

Eur Radiol. 2015 Nov;25(11):3368-71. doi: 10.1007/s00330-015-3748-6. Epub 2015 Apr 23.

PMID:
25903713
42.

Tuberculosis transmission from healthcare workers to patients and co-workers: a systematic literature review and meta-analysis.

Schepisi MS, Sotgiu G, Contini S, Puro V, Ippolito G, Girardi E.

PLoS One. 2015 Apr 2;10(4):e0121639. doi: 10.1371/journal.pone.0121639. eCollection 2015. Review.

43.

Incidence of carbapenem-resistant gram negatives in Italian transplant recipients: a nationwide surveillance study.

Lanini S, Costa AN, Puro V, Procaccio F, Grossi PA, Vespasiano F, Ricci A, Vesconi S, Ison MG, Carmeli Y, Ippolito G; Donor-Recipient Infection (DRIn) Collaborative Study Group.

PLoS One. 2015 Apr 2;10(4):e0123706. doi: 10.1371/journal.pone.0123706. eCollection 2015.

44.

The added value of long-lasting preparedness for the management of a patient with Ebola.

Di Caro A, Puro V, Fusco FM, Capobianchi MR, Lanini S, Lauria FN, Meschi S, Nisii C, Petrosillo N, Nicastri E, Pittalis S, Travaglini D, Vairo F, Ippolito G.

Eur J Intern Med. 2015 Jul;26(6):451-2. doi: 10.1016/j.ejim.2015.03.005. Epub 2015 Mar 27. No abstract available.

PMID:
25818036
45.

Ebola in West Africa: who pays for what in the outbreak?

Ippolito G, Puro V, Piselli P.

New Microbiol. 2015 Jan;38(1):1-3. Epub 2015 Jan 1. No abstract available.

46.

Letter to the editor: management of patients with Ebola virus disease in Europe: high-level isolation units should have a key role.

Ippolito G, Puro V, Brouqui P, Lauria FN, Fusco FM; EuroNHID Consortium.

Euro Surveill. 2014 Dec 18;19(50):20993. No abstract available.

47.

Acute HIV infection (AHI) in a specialized clinical setting: case-finding, description of virological, epidemiological and clinical characteristics.

Ammassari A, Abbate I, Orchi N, Pinnetti C, Rozera G, Libertone R, Pierro P, Martini F, Puro V, Girardi E, Antinori A, Capobianchi MR.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19676. doi: 10.7448/IAS.17.4.19676. eCollection 2014.

48.

Isolation facilities for highly infectious diseases in Europe--a cross-sectional analysis in 16 countries.

Schilling S, Fusco FM, De Iaco G, Bannister B, Maltezou HC, Carson G, Gottschalk R, Brodt HR, Brouqui P, Puro V, Ippolito G; European Network for Highly Infectious Diseases project members.

PLoS One. 2014 Oct 28;9(10):e100401. doi: 10.1371/journal.pone.0100401. eCollection 2014.

49.

Triple therapy for hepatitis C improves viral response but also increases the risk of severe infections and anaemia: a frequentist meta-analysis approach.

Lanini S, Mammone A, Puro V, Girardi E, Bruzzi P, Ippolito G.

New Microbiol. 2014 Jul;37(3):263-76. Epub 2014 Jul 1.

50.

A large epidemic of hepatitis B in Serbia: an integrated model for outbreak investigations in healthcare settings.

Lanini S, Ćosić G, Menzo S, Puro V, Đurić P, Garbuglia AR, Milošević V, Karać T, Capobianchi MR, Ippolito G.

Infect Control Hosp Epidemiol. 2014 Jun;35(6):732-5. doi: 10.1086/676432. Epub 2014 Apr 23.

PMID:
24799653

Supplemental Content

Support Center